Tailoring oral lung cancer treatments to specific mutations
New chemotherapeutic agents are now available for some forms of lung cancer
28th January 2016
Lung cancer is the leading cause of cancer mortality in Australia, and continues to carry a poor prognosis compared with other solid organ malignancies, even when diagnosed early.
The majority of lung cancer cases are associated with a history of tobacco use. However, around 10% of patients diagnosed with lung cancer will have no significant smoking history. In these patients, other risk factors, such as pollution, burning biomass inhalation and genetic mutations, may play causative roles.
Standard management
The majority of lung cancer patients